隆突性皮肤纤维肉瘤的临床结局。来自日本骨与软组织肿瘤（BSTT）登记处的报告。

Clinical Outcome of Dermatofibrosarcoma Protuberance. Report From the Bone and Soft Tissue Tumor (BSTT) Registry in Japan.

机构信息

Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu, Japan;

Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.

出版信息

In Vivo. 2021 Jan-Feb;35(1):611-615. doi: 10.21873/invivo.12298.

DOI:10.21873/invivo.12298

PMID:33402516

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7880785/

Abstract

BACKGROUND

Owing to its rarity, dermatofibrosarcoma protuberance (DFSP) is often inappropriately excised. After unplanned excision (UE), additional excision is commonly performed. We aimed to elucidate the effect of additional excision after UE.

PATIENTS AND METHODS

We examined 306 patients with primary DFSP. We analyzed surgical outcomes in 291 patients who received planned excision (PE) or additional excision after UE.

RESULTS

Of 306 patients, 194 received PE and the remaining 112 received UE. Of 112 patients, 97 received additional excision after UE. Additional surgery due to complications was more frequent in patients with UE than in those with PE. The 5-year local recurrence-free rate in patients without additional excision after UE was significantly worse than that in those with additional excision after UE.

CONCLUSION

If UE is performed, we recommend additional excision for preventing local recurrence; however, the surgical wound should be carefully observed.

摘要

背景

由于其罕见性，隆突性皮肤纤维肉瘤（DFSP）常被不当切除。在非计划性切除（UE）后，通常需要进行额外的切除。我们旨在阐明 UE 后额外切除的效果。

患者和方法

我们检查了 306 例原发性 DFSP 患者。我们分析了接受计划性切除（PE）或 UE 后额外切除的 291 例患者的手术结果。

结果

306 例患者中，194 例接受了 PE，其余 112 例接受了 UE。在 112 例患者中，97 例在 UE 后接受了额外的切除。UE 患者比 PE 患者因并发症而进行额外手术的频率更高。UE 后未行额外切除的患者 5 年局部无复发生存率明显差于 UE 后行额外切除的患者。

结论

如果进行 UE，我们建议行额外切除以预防局部复发；然而，应仔细观察手术伤口。

相似文献

Clinical Outcome of Dermatofibrosarcoma Protuberance. Report From the Bone and Soft Tissue Tumor (BSTT) Registry in Japan.

In Vivo. 2021 Jan-Feb;35(1):611-615. doi: 10.21873/invivo.12298.

A comparison of clinical outcomes between additional excision after unplanned and planned excisions in patients with soft-tissue sarcoma of the limb : a propensity matching cohort study.

Bone Joint J. 2021 Dec;103-B(12):1809-1814. doi: 10.1302/0301-620X.103B12.BJJ-2021-0037.R1.

The incidence of unplanned excision in patients with soft tissue sarcoma: Reports from the Bone and Soft Tissue Tumor registry in Japan.

J Orthop Sci. 2022 Mar;27(2):468-472. doi: 10.1016/j.jos.2020.12.025. Epub 2021 Feb 5.

Analysis of the patients with soft tissue sarcoma who received additional excision after unplanned excision: report from the Bone and Soft Tissue Tumor Registry in Japan.

Jpn J Clin Oncol. 2017 Nov 1;47(11):1055-1059. doi: 10.1093/jjco/hyx123.

Oncological and functional outcomes of planned and unplanned excision of soft tissue sarcoma: A retrospective study.

J Orthop Sci. 2023 Jul;28(4):867-873. doi: 10.1016/j.jos.2022.04.007. Epub 2022 Apr 28.

Is no additional excision after unplanned excision with positive margins justified in patients with small (≤5 cm) high-grade soft-tissue sarcoma?: Analysis from the Bone and Soft Tissue Tumor registry in Japan.

J Orthop Sci. 2022 Mar;27(2):463-467. doi: 10.1016/j.jos.2020.12.022. Epub 2021 Feb 4.

Mohs micrographic surgery and dermatofibrosarcoma protuberans: a multidisciplinary approach in 44 patients.

Ann Plast Surg. 2008 Jun;60(6):667-72. doi: 10.1097/SAP.0b013e31813376a5.

Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.

Cancer. 2004 Mar 1;100(5):1008-16. doi: 10.1002/cncr.20051.

A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control.

World J Surg Oncol. 2017 Jan 5;15(1):5. doi: 10.1186/s12957-016-1075-2.

Conservative Re-excision is a Safe and Simple Alternative to Radical Resection in Revision Surgery for Dermatofibrosarcoma Protuberans.

Ann Surg Oncol. 2020 Mar;27(3):919-923. doi: 10.1245/s10434-019-08011-5. Epub 2019 Oct 29.

本文引用的文献

Oncological outcome, functional results and costs after unplanned excision of musculoskeletal soft tissue sarcoma.

Eur J Surg Oncol. 2020 May;46(5):898-904. doi: 10.1016/j.ejso.2020.01.025. Epub 2020 Jan 30.

Perspectives of Patients With Dermatofibrosarcoma Protuberans on Diagnostic Delays, Surgical Outcomes, and Nonprotuberance.

JAMA Netw Open. 2019 Aug 2;2(8):e1910413. doi: 10.1001/jamanetworkopen.2019.10413.

Dermatofibrosarcoma Protuberans Re-excision and Recurrence Rates in the Netherlands Between 1989 and 2016.

Acta Derm Venereol. 2019 Nov 1;99(12):1160-1165. doi: 10.2340/00015555-3287.

Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation Rate.

Ann Surg Oncol. 2019 Oct;26(11):3526-3534. doi: 10.1245/s10434-019-07494-6. Epub 2019 Jul 23.

Dermatofibrosarcoma protuberans: surgical management of a challenging mesenchymal tumor.

World J Surg Oncol. 2019 May 28;17(1):90. doi: 10.1186/s12957-019-1627-3.

Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated?

Cancer. 2019 Mar 1;125(5):735-741. doi: 10.1002/cncr.31924. Epub 2019 Jan 15.

Relapse in dermatofibrosarcoma protuberans: A histological and molecular analysis.

J Surg Oncol. 2018 Apr;117(5):845-850. doi: 10.1002/jso.25039. Epub 2018 Mar 6.

Analysis of the patients with soft tissue sarcoma who received additional excision after unplanned excision: report from the Bone and Soft Tissue Tumor Registry in Japan.

Jpn J Clin Oncol. 2017 Nov 1;47(11):1055-1059. doi: 10.1093/jjco/hyx123.

A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control.

World J Surg Oncol. 2017 Jan 5;15(1):5. doi: 10.1186/s12957-016-1075-2.

Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States.

Dermatol Surg. 2016 Jan;42 Suppl 1:S24-31. doi: 10.1097/DSS.0000000000000300.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

隆突性皮肤纤维肉瘤的临床结局。来自日本骨与软组织肿瘤（BSTT）登记处的报告。

Clinical Outcome of Dermatofibrosarcoma Protuberance. Report From the Bone and Soft Tissue Tumor (BSTT) Registry in Japan.

机构信息

Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu, Japan;

Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.

出版信息

In Vivo. 2021 Jan-Feb;35(1):611-615. doi: 10.21873/invivo.12298.

DOI:10.21873/invivo.12298

PMID:33402516

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7880785/

Abstract

BACKGROUND

PATIENTS AND METHODS

We examined 306 patients with primary DFSP. We analyzed surgical outcomes in 291 patients who received planned excision (PE) or additional excision after UE.

RESULTS

CONCLUSION

If UE is performed, we recommend additional excision for preventing local recurrence; however, the surgical wound should be carefully observed.

摘要

背景

由于其罕见性，隆突性皮肤纤维肉瘤（DFSP）常被不当切除。在非计划性切除（UE）后，通常需要进行额外的切除。我们旨在阐明 UE 后额外切除的效果。

患者和方法

我们检查了 306 例原发性 DFSP 患者。我们分析了接受计划性切除（PE）或 UE 后额外切除的 291 例患者的手术结果。

结果

结论

如果进行 UE，我们建议行额外切除以预防局部复发；然而，应仔细观察手术伤口。

隆突性皮肤纤维肉瘤的临床结局。来自日本骨与软组织肿瘤（BSTT）登记处的报告。

Clinical Outcome of Dermatofibrosarcoma Protuberance. Report From the Bone and Soft Tissue Tumor (BSTT) Registry in Japan.

机构信息

出版信息

BACKGROUND

PATIENTS AND METHODS

RESULTS

CONCLUSION

背景

患者和方法

结果

结论

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

隆突性皮肤纤维肉瘤的临床结局。来自日本骨与软组织肿瘤（BSTT）登记处的报告。

Clinical Outcome of Dermatofibrosarcoma Protuberance. Report From the Bone and Soft Tissue Tumor (BSTT) Registry in Japan.

机构信息

出版信息

BACKGROUND

PATIENTS AND METHODS

RESULTS

CONCLUSION

背景

患者和方法

结果

结论